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Comparison of neuronal and non-neuronal membrane transport of, 
and neuroexcitation by, the dicarboxylic amino acids bring out pro- 
vocative similarities in structural selectivity, and hence in the 
strategies for studying them. Parallel anomalies in stereoselecti- 
vity show for both phenomena that the recognition sites are indeed 
chiral, as expected for biological functions, even though both fail 
in special instances to discriminate between DL pairs. High and low 
affinity, or Na+-dependence or Na+-independen~e, are not fully re- 
liable bases for discriminating receptor sites serving one of these 
functions. Tolerance of N-methylation of the amino acid serves in 
discriminating families of recognition sites for both phenomena, as 
does substitution of the sulfonate or sulfinate for the distal car- 
boxylate group, or other structural changes. Analogs in which the 
functional groups of aspartate or glutamate are presented in re- 
strained arrays serve for both, although they have so far suggested 
identity neither of recognition sites for transport and excitation, 
nor of the events consequent to binding for these two phenomena. 
We call attention here to some features of the membrane transport of 
dicarboxylic amino acids by hepatocytes, hepatoma cells and fibroblasts that 
bear suggestive relations either to neurotransmittory effects or to membrane 
transport in neural tissue of similar amino acids. One of us suggested in 1972 
that transport behavior of amino acids might be directly pertinent to the ques- 
tion of how neurotransmittory effects are produced (i). Ancillary relations 
between these two phenomena in the meantime have become more obvious, but an 
identity of any known transport system to synaptic signaling has by no means 
emerged. Possible relations between neurotransmitter receptor sites and CNS 
transport receptor sites have in general not been ignored; we seek here to stim- 
ulate attention to the lessons Of amino acid transport outside the central ner- 
vous system, and to show that the same sort of chemical recognition may be in- 
volved, to a degree that may render continuing comparisons instructive. 
The membrane transport studies considered here will exclude from considera- 
tion migrations where the dicarboxylic amino acid appears to be accepted by a 
neutral transport system as a neutral zwitterion (e.g. glutamic acid), usually 
at low pH, rather than as an anion (e.g. glutamate). This exclusion we empha- 
size by use of the more restrictive term, anionic amino acids, instead of the 
more familiar one, dicarboxylic amino acids. The distinction is necessary in 
transport study. Agonistic action appears also to be restricted to anionic 
amino acids or their analogs, although the restriction is less clear for antag- 
onistic action. At the same time we will try to avoid the confusion that may 
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arise from use of the historic names, glutamic acid or kainic acid, when we are 
in fact referring to an anion, glutamate or kainate. Tests to determine the 
molecular species accepted for transport usually proceed by manipulating either 
the pH of the medium of origin of the amino acid or, by structural changes, the 
! 
pK 2 applying to the anionic amino acid. The first technique, that of pH varia- 
tion, allowed the demonstration that in a system also transporting glutamate, 
cystine reacts in the form of an anion (2,3), but the technique seems to have 
been applied less regularly, perhaps for technical reasons, in confirming that 
it is indeed the anionic species of dicarboxylic amino acid analogs that affect 
the neuronal responses. The antagonistic action of diaminopimelate to anionic 
amino acid agonists seems likely to prove due selectively to the anionic species 
in which one of its amino groups is deprotonated, just as for the action of 
cystine on glutamate transport. The second technique utilizes not only dicar- 
! 
boxylic compounds but also sulfonic, sulfinic, phosphonic, or other low pK 
analogs of aspartate and glutamate. Their low pK' values assure that the pro- 
portion of these analogs present in a transportable zwitterionic form will be 
very small. Evidence of the latter kind points to the anionic form as the reac- 
tive species also in producing neurotransmittory effects, although alternativ~ 
possibilities again have been less uniformly excluded for antagonistic action. 
St ereos~ecificit ~. The hepatocyte Na+-dependent transport system mainly 
considered for our illustrations here handles both ~-aspartate and ~-glutamate 
at nearly equal affinities. In correspondence to these balanced affinities, 
this system is designated XAG. The designations XA and XG serve then for sys- 
tems with major preferences for aspartate and glutamate, respectively, although 
x~ has been adopted instead of XG where cystine is also a substrate. System 
XAG is the one also showing an anomaly in stereoselectivity in the mature hepa- 
tocyte which seems to us instructive for the interpretation of related anomalies 
seen in neurotransmittory effects: little transport selectivity is shown by Sys- 
tem XAG of the hepatocyte for ~-aspartate over ~-aspartate, whereas ~-glutamate 
is about ten times as transport-reactive as its ~-antipode (4), not an unusual 
degree of stereospecificity for transport. Somewhat the same anomaly in stereo- 
selectivity for anionic amino acid transport was seen earlier in Neurospora, for 
which ~-aspartate is preferred over its antipode (5), later in cultured cere- 
bellar cells (6), along with a related one for glutamic and aspartic acids in 
the Ehrlich cell at low pH (7). The accompanying diagram shows the several test 
substrates with their functional groups arranged in space to show how the com- 
ponents of the receptor site of such a transport-mediating system may recognize 
these complementary structures on the substrates. We propose that the trans- 
port receptor site is constituted with a special geometry, of course not exactly 
that shown here in two dimensions, and with distances between subsites such 
that it can accept either a formate or an acetate group on each side of the e- 
carbon and its charged amminium group. Hence ~-aspartate can bind nearly as 
well as ~-aspartate, but with an inverted placement of its carboxylate groups. 
In other words it is received as a B- rather than an e-amino acid. The case 
can be likened to a glove fingered so crudely that it can fit either the left 
or the right hand, without violating however the need for a hollow palm. 
~-Cysteate shows similarly high transport reactivity, whereas its enantiomorph 
hh~ws much lower if any reactivity (4). The latter result shows that of the 
recognition points for the carboxylate groups only the distal can accept the 
sulfonate group in place of a carboxylate; hence stereospecificity is recovered 
by the sulfonate-for-carboxylate substitution. The unsuitability of the distal 
sulfonate may be one of bulkiness, or of the chemical mode of bonding rather 
than of limitations of space. The receptor site appears, however, to accept 
poorly the propionate group when presented to the site by the ~-glutamate mole- 
cule at the "wrong" side of the e-carbon, even though the results with aspartate 
indicate that the acetate can be accommodated at either side of the site. We 
can liken glutamate to a hand on which the thumb stands too far away from the 
index finger for the D-isomer to fit our imaginary glove. The finding that 3- 
aminoglutarate (a really symmetrical hand, so to speak) is transported as well 
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as glutamate (4) shows that the acetate group can indeed by accommodated at 
either side of the recognition site, and supports the view that it is the extra 
space or distance required for the propionate group that allows stereoselecti- 
vity for glutamate but scarcely for aspartate. We need to note also the exam- 
ple of low stereoselectivity of glutamate for its membrane transport into a 
mouse leukemia cell (8). The system concerned in that case does not accept 
aspartate. It may be significant that the anomaly in stereoselectivity of 
transport is seen so far for the shortest identified substrate, and in the leu- 
kemia cell stereoselectivity may yet emerge between the two stereoisomers of 
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Anomalous stereoselectivity applies not only for neural excitation by as- 
partate and its higher homologs (9), but also for transport into neural tissues 
(e.g. i0,ii) from various species and anatomical sites. We select a recent 
study to illustrate the transport anomaly (12). In this case, the rate of up- 
take of ~-aspartate by vesicles prepared from rat brain synaptosomes was de- 
creased to 4% by excess ~-aspartate, and to 6% by the same excess of either ~- 
aspartate or =L-glutamate. But Q-glutamate at the same level was only weakly in- 
hibitory, no more so than glycine. Neuronal transport of D- and ~-aspartate, 
and of L-, but scarcely D-glutamate, has been well verifie~ to occur by a common 
medlatzng system by showlng conslstency of K i and K m values (13). When we turn 
to the neuroexcitatory effects, the D-isomers of both aspartate and glutamate 
are effective at the so-called NMDA ~N-methyl-D-aspartate) population of neuro- 
receptors (9; see reviews 14-16). 3-Aminoglutarate has also been found neuro- 
excitatory (9). Along with the isomers of the dicarboxylic amino acids beth L- 
and ~-homocysteate (along with ~-cysteate) take their places in that order in 
the list of antagonists effective at these receptors, whereas only their L-iso- 
mers appear in the list for another class of receptors for neuroexcitation (14- 
17). 
We have already seen from the case of anionic amino acid transport in 
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Neurospora (5) that an unevenly expressed chirality may be built into transport 
receptor sites of the XAG type in a manner to favor the D rather than the L 
isomer. Hence a preference for D isomers in neurotransmTttory action woul~ not 
violate the precedents as to discrimination of these isomers seen in membrane 
transport. Nor does the neurotransmitter activity seen for both stereoisomers 
of anionic amino acids in which the anionic groups are more than 4 carbon atoms 
apart need to raise doubts about applicability of the explanation of our dia- 
gram. Whereas ~-aminoadipate is a neuroexcitant, ~-~-aminoadipate and its ana- 
log, ~-2-amino-5-phosphonovalerate, have been identified as strong, rather spe- 
cific antagonists for the NMDA population of neuroreceptors (14-17). Also an- 
tagonistic is y-D-glutamylglycine, which rather than being a typical dipeptide 
is in fact an amino acid analogous in structure to the antagonistic ~-~-amino- 
pimelate, with the peptide N in the y-dipeptide interpolated for one of the 
methylene groups in the e-aminopimelate (14). Given that the receptor site pro- 
vides enough space for the side chains of longer analogs to curve into confor- 
mations appropriately stabilized by environmental structures, the two anionic 
groups can be brought as close or closer together on binding as are the two 
carbexylate groups of aspartate, a possibility that might apply for one molecule 
but not for a slightly different one. Given that chirality may favor either 
the ~ or the ~ isomer, on occasion R-glutamate or ~-homocysteate may be more 
reactive with a receptor_than their antipodes or than ~-aspartate,a relation not 
yet illustrated by our XAG model. Our experiments have generally observed only 
a single optimum for substrate molecular length at the hepatic transport recep- 
tor sites. 
The threo and erythro isomers of 3-hydroxyaspartate demonstrate another 
point of chirality in a N~a+-dependent, high-affinity transport into rat brain 
slices. In fact, the relation between the positions taken by the 3-hydroxy and 
the 2-amino groups proved more critical than the absolute configuration on car- 
bon 2 (18). The high transport activity achieved with it allows the threo iso- 
mer to intensify the excitatory effect of glutamate by inhibiting its removal 
by transport. It is not a new phenomenon in membrane transport for chirality 
to be intensified by features of the substrate molecule absent in most of the 
substrates of the given transport system. For example, System L in the Ehrlich 
cell shows rather weak preferences between the stereoisomers of its ordinary 
neutral amino acid substrates, such as phenylalanine. Stereospecificity is, 
however, sharply decreased for amino acids with certain unrequired side chain 
structures that cause unusually steep accumulation. The System L uptake of the 
L isomers of azaleucine, thialysine and e-hydrolysine is far faster and more 
~oncentrative than that of their D isomers (19). = 
The generalization extracted here is that the chirality inherent in biolog- 
ical affinity and recognition may not be fully and uniformly signaled in the 
recognition process. Is it not at the same time a significant similarity that 
at least one receptor site for transport and one for neural excitation show 
much the same incompleteness of stereoselectivity? In any case, the doubts ex- 
pressed on the latter account about the role of aspartate and glutamate in neu- 
ral transmission (e.g. 20) appear unjustified. An experimental advantage con- 
tributed by a ~ amino acid over ~, its antipode, namely a greater stability to 
enzymatic attack, could also contribute to apparently stronger and more pro- 
longed action. The possibility has also been considered that an analog might 
mimick agonistic effects by trans stimulation of exodus of an endogenous ago- 
nist if it thereby increased the level of the agonist in the synaptic cleft (21) 
The horizontal cells of the goldfish retina are depolarized by either L- 
glutamate or ~-aspartate, but only at millimolar concentrations. The effects of 
~-glutamate are, however, potentiated 15-fold by exposure of the tissue to ~- 
aspartate, which also augments their electrical response to light (22). ~-aspar- 
tate is able to block uptake of both of the dicarboxylic amino acids; so the 
potentiation of the effect of ~-glutamate might arise from protection of its 
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supply from depletion, or from other effects on its distribution. The rods of 
the goldfish retina accumulate ~-glutamate by a high affinity system with a 30- 
fold preference over aspartate. Hence L-glutamate might serve as a specific 
neurotransmitter in this cell type. Red-sensitive and green-sensitive cones 
instead accumulate both L- and ~-aspartate, also L-glutamate but not ~-gluta- 
mate, with little selectivity among the first three (23). This result bears an 
obvious parallelism to the transport behavior of the hepatocyte and of vesicles 
prepared from synaptosomes. The blue-sensitive cones show relatively little up- 
take of any of these anionic amino acids. Blockade with 2,3-piperidinedicar- 
boxylate has served to differentiate two classes of synaptic receptors that med- 
iate cone influence in the outer retina in Necturus (24). These results support 
further the view that the endogenous transmitter is an excitatory amino acid. 
TABLE I 
Inhibition of Na+-Dependent L-Glutamate Uptake Via System - 
Hepatoma Ce~is by Amino Acid Analogs XAG 
into H35 
K i values 
Inhibitor mM ± S.E. Inhibitor 
v, % of control 
+l mM +5 mM 
~-Aspartate 0.012 ± 0.002 
~-Aspartate 0.0093 ± 0.0015 
~-Cysteate 0.0058 ± 0.0007 
~-Cysteate 0.46 ± 0.i0 
~-Cysteinesulfinate 0.0083 ± 0.0012 
L-Glutamate 0.029 ± 0.004 
~-Glutamate > 5 mM 
~ -Homocysteate > 5 mM 
~-Homocysteate > 5 mM 
~-e-Aminoadipate 0.76 ± 0.07 
~-e-Aminoadipate > 5 mM 
~-~-Aminopimelate 1.8 ± 0.4 
L-Cystine > 1 mM 
~-Threonine 1.3 ± 0.2 
~-Methyl-~-aspartate 28 22 
~-Methyl-~-glutamate 75 97 
N-Methyl-~-aspartate 37 26 
N-Acetyl-~-aspartate 62 29 
N-Methyl-~-glutamate 105 120 
~-Aspartate-B-hydroxamate 12 i.i 
~-Glutamate-y-hydroxamate i00 i00 
l-Aminocyclohexane-l,2- 
trans-dicarboxylic acid 49 33 
Same, cis isomer 78 93 
3-Aminoglutarate* 0 0 
(±)-Cis 2,5-piperidine- 
dicarboxylate (2,5-PDA) I00 72 
(±)-Cis 2,6 PDA ii0 85 
Trans-~-carbox~cyclo- 
propylglycine 96 Not det 
Same, cis isomer* 5 Not det 
Kainate 0 0 
Left, K i values in approximate order of increasing chain length, determined 
using 4 selected glutamate and 6 selected inhibitor concentrations by computer 
fit to the equation for competitive inhibition. Right, velocity of uptake of 
25 ~M ~-glutamate as per cent of unlnhlblted rate. Contrastlng results on Sys- 
tems x~ and x~, M. Makowske and H. N. Christensen, to be published. 
Chain length and N-meth. ylation. Table I, left, shows the effect of chain 
length on the K i values of anionic amino acids as inhibitors of glutamate uptake 
via System X~G of the hepatoma cell line H4-11-EC,3, here referred to as H35. 
This cell line has been selected here for its greater ease of study than the 
mature rat hepatocyte and because of the similarity of its glutamate transport 
to that of the hepatocyte (4), in contrast with the fetal hepatoc[te and the 
hepatoma cell line, HTC (3). The transport system under study, XAG , seems like- 
ly to be the same one as the Na+-dependent, high-affinity system detected by 
Logan and Snyder in their search for an agency by which the hypothetical neuro- 
nal transmitter pools of aspartate and glutamate may be generated. Synaptosomes 
prepared from rat cerebral cortex showed in their study a Km of 16.9 ~M for as- 
partate uptake, and a Km of 36 ~M for glutamate uptake (25), values very simi- 
lar to those seen for X~G in H35 (Table I, left), and hence carrying no implica- 
tion of unique service in the neurone. Low half-saturation levels are seen for 
fibroblasts (26) and various other cells, and appear not to justify separate 
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treatment of amino acid uptake in neural and non-neural tissues. Highest affin- 
ity binding sites no longer tend necessarily to be accorded top significance 
for neural transmission. The right hand panel shows further comparisons of 
analog inhibition of glutamate uptake by the same system. We have reported 
elsewhere similar tests of various other hepatoma cell lines, and of fetal and 
mature rat hepatocytes (3,27,28). Ineffective inhibitors of the uptake of 25 ~M 
glutamate in H35 during 1 min will show readings of nearly i00 in both columns 
of Table I, right, i.e. at both 1 and 5 mM. Reservations as to possible effect~ 
of trace impurities may need to be entertained for higher concentrations. We 
note first by the inhibition of glutamate uptake that the transport reactivity 
of ~-aspartate is retained after its N-methylation, whereas for ~-glutamate 
the same step causes loss of essentially all inhibitory action. For the other 
Na+-dependent system for anionic amino acid uptake by hepatocytes, XA, N-meth- 
ylation of either aspartate or glutamate leaves no inhibitory action on uptake 
of the preferred amino acid substrate, cysteinesulfinate (3,27,28). Similarly, 
for Na+-independent System Xc as tested in hepatoma line HTC, neither retains 
inhibition of glutamate transport on N-methylation. Such inter-system differ- 
ences in tolerance to N-methylation are already familiar for the neutral amino 
acid transport systems, two being highly tolerant (A and Gly) and at least two 
entirely intolerant (ASC and L). N-Methylation of amino acid substrates of 
transport has accordingly long (29) been an important strategy for systems dis- 
crimination (30). Neuroscientists have speculated that the N-methyl group 
introduced into the ~-aspartate molecule, by diminishing the extent to which 
the carbon chain tends to fold, intensifies the agonistic action with the NMDA 
population of neuronal receptors. 
Hydroxamates. Next in Table I, right, we note the contrast between the 
effects of converting ~-aspartate and L-glutamate to their ~u-hydroxamates. This 
conversion presumably raises the pK' of the distal anionic group (31), pro- 
bably an unfavorable effect, and lengthens by one nitrogen atom the separation 
of the two anionic groups. These compounds also bear structural relations to 
the transmitter antagonist HA-966 (32). For aspartate this conversion to its 
hydroxamate does not greatly decrease reactivity with transport via System X~G 
of H35, whereas the reactivity of glutamate appears to be eliminated by con- 
version to its ¥-hydroxamate. From the comparison with the effects of chain 
length on K i seen in Table I, left, the former molecule should logically not 
have become too long, whereas the latter molecule might well have become long 
for System X~G. In contrast, the action of L-glutamate on transport by System 
x~ persists after its conversion to the y-hydroxamate as tested in hepatoma 
line HTC, a predictable effect because this system has room for longer amino 
acid chains as in e-aminopimelate and cystine, although apparently not for the 
extreme length of homocystine (3). The inappreciable reactivity of aspartate 
with the same System Xc in HTC remains scarcely appreciable on lengthening to 
the 8-hydroxamate (Table II in ref. 3). 
Only weak neuroexcitation has been found for the ~-hydroxamates of L-glu- 
tamic and~-aspartic acid, whereas these analogs were among the stronge~ in- 
hibitors of the high-affinity uptake of ~-glutamate by rat dorsal root glia 
and cerebral synaptosomes (32,33). In contrast, substances that antagonize 
amino acid-induced excitation of central neurones were found without effect on 
glutamate uptake. In another test ~-glutamate-y-hydroxamate at 5 mM was as 
effectiv~ as L-glutamate at 1 mM in stimulating neuronal efflux of previously 
loaded 2 Na + ~34). This behavior could have a number of explanations, includ- 
ing a transmembrane exchange of amino acid and Na + together across the plasma 
membrane by a Na+-dependent transport system. 
Restrained analogs i n_ndiscriminating receptor sites. Ring formation is 
often used to restrain the positions that the chemical groups of amino acids 
can take in space for receptor recognition. The second and third populations 
of agonistic sites, namely the quisqualate- (35) and kainate-responsive 
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populations, are presumably discriminated by these agents on that basis. Among 
three piperidine dicarboxylates, the 2,3-dicarboxylate (2,3-PDA), already men- 
tioned for retinal photoreceptors (24), identifies the NMDA receptors. 2,5-PDA 
is in turn fairly selective for the quisqualate population (36,37), although 
that group is better identified by its sensitivity to blockade by iontophoreti- 
cally applied glutamic acid diethylester. Although unfortunately we did not 
have access to 2,3-PDA, neither 2,5-PDA nor 2,6-PDA showed appreciable inhibi- 
tion of XAG transport in H35 (Table I, right). This table also compares the 
inhibition of glutamate uptake via System x?_ by the two conformers of amino- 
cyclohexane-l,2-dicarboxylic acid (7), analogous to 2,3-PDA. Comparison of the 
acid-base properties of these isomers places the amino group of one between the 
two carboxylate groups, which thus lie in a trans relation. This trans confor- 
mer is a fairly effective inhibitor of X~G , whereas the cis conformer appears 
devoid of inhibition (Table I). Neither conformer has appreciable action on 
transport systems XA and Xc, tested with their preferred substrates, CySO5 and 
glutamate. 
The sharpest inter-system contrast we obtained among restrained glutamate 
analogs is seen with the a-carboxycyclopropylglycine isomers of Fowden et al. 
(38). The cis form is a potent inhibitor of glutamate transport by X~G (Table 
I), whereas the trans isomer is ineffective. System x c shows a sharply oppo- 
site selectivity (unpublished results, M. M~kowske and H. N. Christensen). This 
contrast tells us that the subsite recognizing the distal anionic group of 
amino acid substrates falls in entirely different positions in the two systems. 
Such differences serve strikingly then to discriminate receptors beth for trans- 
port and neuroexcitation. Although without effect on either x- or x~, kainate 
• A 
proved a potent inhibitor of XAG in H35 (Table I) - conceivably its K i may prove 
low enough to correspond to its intense agonistic potency in neurones. Along 
with quisqualate, kainate has offered the hope of showing binding related only 
to its pharmacologic action. Its high transport reactivity with x~_ may occa- 
sion some rethinking, and intensifies our interest in the neurochemlcal function 
of this widely distributed transport system. Perhaps the Na+-independent neu- 
ronal binding of kainate may prove more homogeneous, although two high-affinity 
components have already been detected (39). 
"Excitotoxic" effects. Several neuroexcitatory analogs behave like gluta- 
mate in producing lesions when applied iontophoretically to specific brain 
areas. Certain retinal (40) and other CNS (41) regions outside the blood-brain 
area may be vulnerable in neonatal rodents to high oral glutamate intake. Al- 
though kainate blocks glutamate uptake weakly, thereby perhaps leading to some 
persistence of elevated glutamate levels in the synaptic area, this effect seems 
not to explain the toxic action of kainate. The resulting brain lesions cause 
effects mimicking Huntington's chorea and epileptic attacks. Since the toxic 
effects apparently result from activation of central excitatory receptors for 
amino acids, these receptors have come to be seen as potential points for phar- 
macological intervention. The neurotoxic action appears, however, to arise 
largely through activation of presynaptic receptors on nerve termini, stimulat- 
ing release of endogenous agonist, although direct excitatory effects of kainate 
are considered postsynaptic (42). When kainate application produces lesions to 
the striatum or the retina, it also causes major losses in their subsequently 
measured high-affinity kainate-binding sites. Furthermore, cell types resis- 
tant to that injury, including retinal rods, carry low densities of such recep- 
tors (43). Nevertheless excitatory responses to kainate persist after cortical 
lesions have been produced by it (44,45). 
Sulfonate and sulfinate analogs ; diamino-dicgrbox~lic acids. We have men- 
tioned the use of ~-cysteate to show that =D-aspartate transport binding involves 
an inverted recognition of the two carboxyl groups. We spoke also of the use- 
fulness of the analog, cysteinesulfinate. We will complete briefly here the 
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story of the substitution of the sulfonate or sulfinate group for the distal 
carboxylate. The increasing reactivity with System XA in hepatoma line HTC 
takes the sequence, ~-aspartate < ~-cysteate < ~-CySO~ (28, Fig. 5). The advan- 
tage of the latter analog over cysteate we attribute tentatively to the similar- 
ity of the space requirement for the -SO~ group to that for the carboxylate 
group. Similar results apply to the fetal hepatocyte and to hepatoma cell line 
H35. Homocysteate presents an ion distinctly too long to be inhibitory to this 
transport system, as shown with various other long-moleculed analogs (Table I; 
Table III in ref. 28), including ~-glutamate. The cysteate and cysteinesulfin- 
ate ions are in turn too short for the sodium-independent transport System x~, 
for which aspartate is also almost inactive as a substrata. Homocysteate is an 
effective inhibitor of System x~, and hence the pair, cysteate and homocysteate 
serve impressively to show the difference in length of the amino acid molecules 
accommodated by the two systems, x A and x~. For System X~G , however, the ab- 
sence of homocysteate inhibition is somewhat anomalous, slnce other anionic 
amino acids of similar length are accommodated. The sulfonate group may be too 
bulky for this recognition site. Among these three systems, only x~ has proved 
responsive to amino acid depletion, and that only after several hours (46). 
Aspartate and cysteate, and particularly CySO~, served for the surprising 
observation that System XA on deprotonation becomes effective for the still Na +- 
dependent transport of neutral amino acids of similar chain length. Conversely 
we observed that protonation of System ASC, when serving for transport of neu- 
tral amino acids, increases its susceptibility to aspartate or cysteinesulfinate 
inhibition of that transport, also to the transmembrane exchange between neutral 
and anionic amino acids. In this way we showed the two transport systems to be 
in fact one and the same (28). The strange result is that the anionic CySO~, 
when applied at pH 5.5 or 6, is so far our best model substrata for System ASC. 
Furthermore an interconvertibility to serve as System x A appears to be a wide- 
spread characteristic of the apparently ubiquitous System ASC. 
with regard to neurotransmission, homocysteate is a strong antagonist for 
both the quisqualate- and the NMDA-preferring receptors, both the ~ and the L- 
isomer serving in the latter case. Although we have noted that the D isomer~ 
and the N-methyl derivatives of the anionic amino acids offer technical advan- 
tages, both as agonists and antagonists, for discriminating and studying the 
NMDA population of neuroreceptor sites, these are artificial analogs, and pre- 
sumably no one supposes them to serve endogenously as neurotransmittory agents. 
Ultimately their structures may bring attention to unknown endogenous agonists. 
In contrast, cysteinesulfinate (CySO~) has been suspected of endogenous action 
as a neurotransmitter (47,48), even though it also was first introduced as an 
artificial analog to mimick endogenous amino acids, both for membrane trans- 
port (e.g. 3,26,27) and for the production of neurotransmittory effects. CySO~ 
is asymmetrically distributed in the rat brain (47), and the enzymes involved 
in both its synthesis (via cysteine oxidase) and its degradation are localized 
in synaptosomes (49-51). Furthermore taurine as a product of its metabolism 
may act as an inhibitory synaptic transmitter, thus contributing further to the 
possible significance of CySO2. In addition, CySO2 at low levels increased the 
cyclic AMP concentrations more strongly than did glutamate in brain slices of 
guinea pigs (52). 
A Na +- and Ca2+-dependent high-affinity uptake system for CySO2 uptake by 
the synaptosome preparation has been described (47). Mitochondria purified 
from the same preparation failed to take up CySO2. The uptake by synaptosomes 
was inhibited by ~-glutamate, ~- and ~-aspartate, and ~-cysteate, but n~t by 
N-methyl-~-aspartate. The inhibition by the three ~ forms was competiaive, 
although that by D-aspartate was not tested for this feature. Depolarization 
by K + at 56 mM or=by veratridine at i0 ~M stimulated a somewhat Ca2+-dependent 
release of previously accumulated [14C]-CySO[ (48). 
z 
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In separate experiments from the same laboratory (53), a Na+-independent 
specific binding site for CySO~ was shown in crude synaptic membranes. Both 
+ ~ • 35 t t . the Na+-dependent and Na -independent sltes were studled wlth [ S]-cys ea e 
The Na+-independent site was considered probably different from that shown for 
glutamate. It is noteworthy that effects of raising and lowering the pH from 
7.4 were tested, binding being sharply decreased both at pH 9 and pH 5. One 
wishes such tests might be reported more often for neural work, particularly 
when tests are made on analogs for which we may expect changes in state of 
charge that might serve to identify the charged species producing effects. We 
can illustrate the problem by speculating whether some of the effects of the 
cationic glutamic acid diethyl ester as a specific inhibitor of the quisqualate- 
preferring receptors might arise from its exceptionally rapid passage across 
cellular membranes at neutral pH, a characteristic of amino acid esters ex- 
ploited to load cells with say leucine, or lysosomes with cystine (54). Sub- 
sequent cleavage within the neurone might then plausibly yield free intracellu- 
lar glutamate to contribute in some unknown way to the action of this antagon- 
ist. Concern has been expressed that this agent shows different effects when it 
is supplied in the bath rather than iontophoretically. Conceivably electro- 
phoresis could tend to release selectively say a monoethyl ester from the ionto- 
phoretic electrode. 
This section has shown that the same sulfur analogs serve for the study of 
the two phenomenon our title proposed to compare. 
Low affinity transport into glia as a possible means of terminatin ~ excit- 
ation. Although interest has often focused on high-affinity transport recep- 
tors for anionic amino acids in relation to neurotransmitter action, attention 
has also fallen on low-affinity, high-capacity transport systems. Such trans- 
ports have frequently been seen as appropriate for a glial uptake that might 
serve to terminate the effects of amino acid excitants in the synaptic cleft 
(55). The question was asked whether N-methyl-~-aspartate produces a prolonged 
excitation because of its rather slow uptake via a glial transport system. A 
potent inhibitor of that uptake was reported however not to influence the ex- 
citant action (56). Histidine potentiates the neurotransmitter effect of quis- 
qualate on the rat spinal cord, presumably by retarding its transport from the 
synaptic region (57). The neurone as indicated earlier may itself participate 
in the recapture of released amino acids. Glutamate captured by the glial 
cells is believed to be converted by them to glutamine, which then may migrate 
back to the neurone for cleavage to free glutamate in the mitochondria (58,59). 
The glutamate may, according to this hypothesis, serve again in a cyclic fash- 
ion. Even disregarding this proposed interconversion, we may face a competi- 
tion among three immediate fates for an excitatory amino acid entering the syn- 
aptic cleft: a perhaps reversible binding at postsynaptic receptors by which a 
message is transmitted; recapture by a presumably high-affinity presynaptic 
transport system that maintains the neuronal pool, e.g. after a second trans- 
port step into Naito and Ueda's vesicle; and its capture by the presumably low- 
affinity system whereby glial cells bring the amino acid below exciting concen- 
trations. It is inherently unlikely that each of these three processes come to 
equilibrium. Instead, excitatory amino acids probably sustain a low steady 
state flow with these fluxes all increased on stimulation (cf. 60). Glial cap- 
ture may not, however, play a major role in these events. Tissue cultures 
grown under conditions that suppress glial multiplication show a time course 
for synaptic excitation little changed from that seen in vivo or in slices. In 
any case membrane transport retains an essential role in the sequence of events. 
Mod___~e of release, excitatory action, and termination of action of the pre- 
sumed neurgexcitatory amino acids. Substantial support is available then for 
roles for glutamate and aspartate, perhaps also for cysteinesulfinate as endo- 
genous neurotransmittory agents. In approaching the question of the mode of 
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their presynaptic release, writers may have been impressed unduly by an analogy 
with the release of hormones through their accumulation in vesicles, followed 
by exocytosis; also by analogy with an imperfectly established mode of acetyl- 
choline release. Until recently, little evidence has been available for the 
accumulation of any of these amino acids into vesicles within the neurone, al- 
though synaptic vesicles had been detected. Now, however, Naito and Ueda have 
developed an ingenious immunologic procedure for isolating from the bovine cer- 
ebral cortex a class of endogenous synaptic vesicles able to accumulate L-glut- 
amate with remarkable specificity in an ATP-dependent, Na+-independent m~nner 
(61). The ability to isolate these vesicles came about from their recognition 
of a kinase-phosphorylated protein characteristically marking the surface of 
these vesicles (62). This protein is an endogenous substrate for beth cAMP- 
dependent and calcium-calmodulin-dependent synaptic protein kinases. Anti- 
bodies to this Protein I then served to isolate vesicles of this class. This 
finding allows us to suppose that the contents of this vesicle may be accumu- 
lated for abrupt release into the synaptic cleft by exocytosis. The specific 
release step may thus at last come to be proved a vesicular transport. 
Finally comes the harder question, how does the release of aspartate or 
glutamate, or the introduction of their agonistic equivalents into the synaptic 
region, produce its physiological effect? What we have seen as to the specifi- 
city of action of various anionic amino acid analogs allows the conclusion that 
one or another of the different populations of receptor sites recognizes them 
by binding them, and that this recognition bears important similarities to that 
initiating transport of amino acids. For both of these processes, given that 
the bound amino acid meets certain structural requirements beyond those allowing 
binding, a second step follows, namely translocation in the one case and neural 
stimulation in the other case. We have for analogy the contrast between the 
binding of leucine or 2-aminonorbornane-2-carboxylic acid for membrane trans- 
port, and its recognition for the stimulation of insulin release from the beta 
cells (63). Despite detailed geometric correspondence in the recognition of 
the latter molecule, the response of the membrane is not the same. Conceivably 
gene duplication has led to roles apparently so different for sites so similar. 
Furthermore, the similarity is too great to encourage interpreting a receptor- 
mediated endocytosis as the mode of response. 
+ 
From an early time depolarization attributed to a Na influx was associa- 
ted with neurostimulatory action, and hyperpolarization with neural inhibitory 
action. We quote from Curtis and Watkins in 1960 (9): 
"The most satisfactory explanation of the difference between the actions 
of the acidic and neutral amino acids is that only the former results 
in the net entry of sodium ions into the cell, thus accounting for the 
observed depolarization." 
+ 
This net entry of Na was not supposed to occur as a stoichiometric consequence 
of dicarbexylic amino acid uptake (i.e. by cotransport), but by a membrane acti- 
vation producing an unspecified Na + permeability. In current terms, do such 
neurotransmitters act by modulating inorganic ion channels, and if so, how? 
Conductance rises in some instances, but falls in others; and excitatory amino 
acids may not always act by modulating ion channels. To add to the complexity, 
anionic amino acids increase cyclic AMP levels in cerebral slices from guinea 
pigs or rats (52). Observations of Ca 2+ uptake concurrent with excitation add 
to the interest. By the use of a patch-clamped electrode, the gating by a glu- 
tamate ion has been anatomically identified with a single ion channel in the 
locust neuromuscular junction (64). Could the apparatus conduct the receptor- 
bound glutamate inward quickly enough to account for channel closing? "..° the 
possibility exists that the induction of a response by glutamate-receptor 
interaction may be closely linked to an uptake system" (65). Whether the 
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excitatory amino acid molecule gives rise to a signal on binding without itself 
crossing the membrane is unknown. Could membrane transport have anything fur- 
ther to offer in explaining the effect? It is not known how an amino acid 
might open an ion channel. We note a weak precedent for a possible relation: a 
single amino acid molecule can serve for the inflow of numerous sodium ions be- 
cause the System ASC carrier may dissociate its bound amino acid from a ternary 
complex less frequently than its sodium ion (66). An extreme case of that be- 
havior might only with difficulty be distinguished from action through a rever- 
sible static surface binding of the excitatory amino acid. The ability of Sys- 
tem ASC to serve for anionic amino acid transport counsels us not to ignore 
such possibilities. Lee and Vidaver have speculated on a signaling function of 
transport by System ASC, in which case cellular Ca 2+ uptake is catalyzed (67). 
Snodgrass closes a discussion with these words: "Studies of mechanism have much 
to explain in the realm of excitatory responses" (16). 
Conclusion. The information so far available suggests that at least three 
separate populations of receptor sites may serve directly in postsynaptic recog- 
nition of amino acids to produce excitation. The information also suggests that 
perhaps a similar number of amino acid transport systems have supportive func- 
tions to the neurotransmittory action at several points. These membrane trans- 
port activities are often much more similar than has been supposed to those in 
non-neural tissues. The evidence indicates further that the chemistry which 
allowed nature to design specific receptor sites for these amino acids for 
transport, and specific receptors for neural impulses, is to a large degree one 
and the same chemistry, both as to the substrates and as to the complementary 
membrane structures recognizing these substrates. Furthermore, the discrimina- 
tion of different populations of synaptic receptor sites involves much the same 
complex strategy as the discrimination of distinct transport systems. Our com- 
parisons and the speculations arising from them perhaps have sufficient merit 
to allow us to urge continued comparison of these classes of recognition sites 
on various cell surfaces. 
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